Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.73 is in line with its 5-year average of 0.72, around the middle of its 5-year range (0.37–1.24).
As of the fiscal period ended Tuesday, June 30, 2026. 10.33% above its 12-month average of 0.66.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.73.
QUICK RATIO (ACID-TEST)
0.73
QUICK RATIO (ACID-TEST) AVG TTM
0.66
QUICK RATIO (ACID-TEST) AVG 3Y
0.71
QUICK RATIO (ACID-TEST) AVG 5Y
0.72
QUICK RATIO (ACID-TEST) AVG 10Y
0.77
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.33%
CURRENT VS 3Y AVG
+2.90%
CURRENT VS 5Y AVG
+1.62%
CURRENT VS 10Y AVG
-4.62%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.21
median of 89 covered companies
CURRENT VS SECTOR MEDIAN
-39.53%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$17.17B
Quick Ratio (Acid-Test)
0.73
TTM Avg
0.66
3Y Avg
0.71
5Y Avg
0.72
Market Cap
$18.23B
Quick Ratio (Acid-Test)
1.69
TTM Avg
1.04
3Y Avg
0.96
5Y Avg
0.94
Market Cap
$15.16B
Quick Ratio (Acid-Test)
0.74
TTM Avg
0.86
3Y Avg
0.93
5Y Avg
0.94
Market Cap
$14.70B
Quick Ratio (Acid-Test)
3.38
TTM Avg
3.54
3Y Avg
3.46
5Y Avg
4.12
Market Cap
$14.08B
Quick Ratio (Acid-Test)
3.16
TTM Avg
2.58
3Y Avg
2.23
5Y Avg
3.05
Market Cap
$13.57B
Quick Ratio (Acid-Test)
1.04
TTM Avg
1.07
3Y Avg
1.10
5Y Avg
1.11
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.17B | 0.73 | 0.66 | 0.71 | 0.72 |
| Revvity, Inc. (RVTY)vs › | $16.37B | 1.50 | 2.21 | 2.02 | 1.79 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.23B | 1.69 | 1.04 | 0.96 | 0.94 |
| Solventum Corporation (SOLV)vs › | $15.16B | 0.74 | 0.86 | 0.93 | 0.94 |
| Exelixis, Inc. (EXEL)vs › | $14.70B | 3.38 | 3.54 | 3.46 | 4.12 |
| Viatris Inc. (VTRS)vs › | $19.95B | 0.96 | 0.86 | 1.00 | 0.90 |
| Tempus AI, Inc. (TEM)vs › | $14.08B | 3.16 | 2.58 | 2.23 | 3.05 |
| STERIS plc (STE)vs › | $20.28B | 1.35 | 1.46 | 1.73 | 1.65 |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.57B | 1.04 | 1.07 | 1.10 | 1.11 |
| United Therapeutics Corporation (UTHR)vs › | $21.11B | 5.41 | 5.66 | 6.29 | 6.48 |
Quick Ratio
0.73
Excludes inventory
Current Ratio
0.73
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.73 |
| 2026-03-31 | 0.85 |
| 2025-12-31 | 0.74 |
| 2025-09-30 | 0.57 |
| 2025-06-30 | 0.43 |
| 2025-03-31 | 0.73 |
| 2024-12-31 | 0.93 |
| 2024-09-30 | 0.99 |
| 2024-06-30 | 0.88 |
| 2024-03-31 | 0.78 |
| 2023-12-31 | 0.64 |
| 2023-09-30 | 0.53 |
| 2023-06-30 | 0.44 |
| 2023-03-31 | 0.42 |
| 2022-12-31 | 0.42 |
| 2022-09-30 | 0.41 |
| 2022-06-30 | 0.37 |
| 2022-03-31 | 0.61 |
| 2021-12-31 | 1.24 |
| 2021-09-30 | 1.24 |
| 2021-06-30 | 1.16 |
| 2021-03-31 | 1.19 |
| 2020-12-31 | 1.08 |
| 2020-09-30 | 1.10 |
| 2020-06-30 | 0.94 |
| 2020-03-31 | 0.89 |
| 2019-12-31 | 0.92 |
| 2019-09-30 | 0.80 |
| 2019-06-30 | 0.66 |
| 2019-03-31 | 0.69 |
| 2018-12-31 | 0.69 |
| 2018-09-30 | 0.66 |
| 2018-06-30 | 0.68 |
| 2018-03-31 | 0.66 |
| 2017-12-31 | 0.67 |
| 2017-09-30 | 0.68 |
| 2017-06-30 | 0.79 |
| 2017-03-31 | 0.85 |
| 2016-12-31 | 0.79 |
| 2016-09-30 | 0.75 |
| 2016-06-30 | 0.83 |
| 2016-03-31 | 0.81 |
| 2015-12-31 | 0.69 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-03-31 | 0.00 |
